JAK1 inhibitor Xibico? New indications for age expansion approved in China
嫦娥的情人矩
发表于 2024-3-4 18:26:40
1232
0
0
Southern Finance and Economics, March 4th - Today, Pfizer announced that it is a highly selective JAK1 inhibitor and an innovative oral small molecule targeted drug called Xibico; Reg; The new indication for age expansion has been officially approved by the National Medical Products Administration (NMPA) of China for the treatment of moderate to severe atopic dermatitis (AD) in adolescents and adults aged 12 and above. (21st Century Business Herald)
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- General Motors Q3 sold over 420000 vehicles in China, surpassing gasoline powered vehicles for the first time in new energy vehicles
- Has the 'fixed price' policy been effective? General Motors' sales in China increased by 14.3% month on month in the third quarter, and SAIC GM's orders for certain models were overstocked
- Hyatt Hotels and China Resources Land establish a joint venture for light asset expansion, continuing to expand into the Chinese market
- The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
- When will Apple AI be launched in China? Cook responds!
- Dialogue with Meng Pu, Chairman of Qualcomm China: Qualcomm has long-term accumulation in China and will adhere to the path of self-developed chips
- Lilly: The first and only non covalent (reversible) BTK inhibitor, Jeparil, has been approved in China
- This US funded enterprise has clarified its confidence and direction for development in China through the CIIE
- Pfizer's innovative targeted therapy drug Taizena has been approved in China
-
【英偉達の需要が高すぎる？SKハイニックス：黄仁勲がHBM 4チップの6カ月前納入を要求！】SKハイニックスの崔泰源（チェ・テウォン）会長は月曜日、インビダーの黄仁勲（ファン・インフン）CEOが同社の次世代高帯域 ...- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;（TALZENNA®，一般名：トルエンスルホン酸タラゾールパーリカプセル）は2024年10月29日に国家薬品監督管理局（NMPA）の承認を得て、HRR遺伝子突然変異 ...- 什么大师特
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...- Dubssgshbsbdhd
- 7 小时前
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた：作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...- 波大老师
- 8 小时前
- 支持
- 反对
- 回复
- 收藏
